Skip to main content

My account

Boston Scientific accounts are for healthcare professionals only.

Create an account to access online training and education on EDUCARE, manage your customer profile, and connect with customer support and service teams.

My Boston Scientific account

Access your online applications and manage your customer profile.

Manage my Boston Scientific account

Quick Links

Contact a representative
Online education and training
Order products online
Reimbursement resources
Return a product
Customer support

Call customer care

1 (888) 272-1001

Boston Scientific’s family of CRT devices

Endoscopy

Our focus

We strive to be an industry leader in endoscopy devices for diagnosing and treating gastrointestinal and pancreaticobiliary conditions, and for supporting weight loss in patients with obesity.

Kyra’s story

This patient testimonial is sponsored by Boston Scientific.  Individual results may vary. In a randomized study, patients with class 1 or class 2 obesity (BMI 30 to 40 kg/m2) who underwent ESG in conjunction with prescribed diet and exercise counseling achieved an average of 13.6% total body weight loss at year one, compared to 0.8% with lifestyle modification alone. In that study, 64.7% of patients who underwent ESG in conjunction with lifestyle changes lost at least 10% TBWL compared to 4.5% of patients with lifestyle modification alone. Approximately 21.2% of patients lost more than 20% of their body weight. Optimal results were achieved when patients committed to long term lifestyle changes around diet and exercise. All procedures have risk, including endoscopic sleeve gastroplasty. Patients should consult with their doctor to discuss risks and benefits of any medical procedure.

By combining a relentless dedication to developing an evolving portfolio of less-invasive technologies with a spirit of collaboration with healthcare professionals, we’re committed to improving patient care through continuous innovation, product development excellence and world-class support within the gastrointestinal and pancreaticobiliary spaces.

Delivering meaningful innovation

Supporting infection prevention and operational efficiency.

The EXALT ™ Model D Single-Use Duodenoscope eliminates the risk of patient-to-patient infection due to ineffective reprocessing and may help realize operational efficiencies during endoscopic retrograde cholangiopancreatography (ERCP) procedures. Now in its fourth generation, the success of the EXALT Model D duodenoscope has been fueled by continuous innovation.

Addressing outcomes.  

The SpyGlass™ DS Direct Visualization System, a single-use, single-operator digital cholangioscope, enables physicians to see high-resolution images from inside the biliary, hepatic and pancreatic ducts during ERCP. When used with the SpyBite™ Max Biopsy Forceps, physicians are enabled to take targeted biopsies of strictures to diagnose diseases such as cholangiocarcinoma or pancreatic cancer. When used with electrohydraulic lithotripsy (EHL) or laser lithotripsy, physicians have the tools to help them effectively and efficiently treat complex biliary stones.

Minimally invasive treatment alternatives.

The AXIOS™ Stent and Electrocautery Enhanced Delivery System offers an endoscopic alternative for transgastric or transduodenal endoscopic drainage of symptomatic pancreatic pseudocysts and certain types of walled-off necrosis, as well as the gallbladder in patients with acute cholecystitis who are at high risk for surgery.*

For people with obesity, endoscopic sleeve gastroplasty performed with the OverStitch™ Endoscopic Suturing System or placement of the Orbera™ Intragastric Balloon System** provide minimally invasive procedural alternatives to losing weight with no external incisions or scars. Both procedures offer proven, effective weight loss when combined with lifestyle changes.

Offering services and solutions.

Boston Scientific offers a range of healthcare services and solutions that are designed to help clinicians in their efforts to maintain costs, improve operational efficiencies and deliver high-quality patient care. We offer a range of infection prevention products and solutions for use in the endoscopy suite.

check icon

Since 2005, SpyGlass™ has impacted more than 300k patients across the globe.1

check icon

Worldwide, over 160K procedures have utilized the AXIOS™ Stent and Electrocautery Enhanced Delivery System.2

check icon

The EXALT™ Model D is the only single-use duodenoscope with 7 peer-reviewed, published studies, involving more than 1,000 patients across all ERCP complexity grades.3,4,5,6,7,8,9

Conditions our customers treat with Boston Scientific products

  • Gastrointestinal Cancers & Diseases
  • Pancreaticobiliary Stones
  • Pulmonary Diseases & Lung Cancer
  • Obesity
  • Upper and Lower Gastrointestinal Bleeding
  • Pancreatitis

3rd

leading cause of cancer death in the U.S.: pancreatic.10

3% to 14%

mortality rates for all patients with GI bleeding.11

40%

of adults suffer from obesity in the US.12

2.8M+

Antimicrobial-resistant infections yearly in the US.13

Products and solutions we offer

  • Biliary Access
  • Biliary Stricture and Stone Management
  • Biopsy
  • Dilation
  • Endoscopic Ultrasound (EUS)
  • Hemostasis
  • Airway
  • Cholangioscopy
  • Stents: Enteral & Esophageal
  • Tissue Resection
  • Endoscopic Mucosal Resection
  • Enteral feeding
  • Radiofrequency ablation
  • Infection prevention
  • Single-use imaging
  • Single-use scopes

Product spotlights

OverStitch™ Endoscopic Suturing System product picture

OverStitch™ NXT Endoscopic Suturing System

The OverStitch™ NXT Endoscopic Suturing System allows for the placement of durable, full-thickness sutures in the GI tract through a minimally invasive approach.

The device system is also indicated for facilitation of endoscopic sleeve gastroplasty, a minimally invasive weight loss procedure for people with obesity.

Learn more about the OverStitch Endoscopic Suturing System
AXIOS™ Stent and Electrocautery Enhanced Delivery System 

AXIOS™ Stent and Electrocautery Enhanced Delivery System

The AXIOS™ Stent and Electrocautery Enhanced Delivery System offers an endoscopic alternative for transgastric or transduodenal endoscopic drainage of symptomatic pancreatic pseudocysts and certain types of walled-off necrosis, as well as the gallbladder in patients with acute cholecystitis who are at high risk for surgery.*

Learn more about the AXIOS Stent
EXALT™ Model D Duodenoscope

EXALT™ Model D Single-use Duodenoscope

The EXALT™ Model D Duodenoscope is the world’s first single-use duodenoscope on the market and provides a new, sterile device for each patient. EXALT Model D uses a familiar duodenoscope design and function that forgoes the need for reprocessing.

Learn more about the EXALT Model D
SpyGlass™ DS Direct Visualization System 

SpyGlass™ DS Direct Visualization System

The SpyGlass™ DS System enables direct visualization of the pancreatic and bile ducts, is used to evaluate suspected benign and malignant conditions, and is used in the treatment of difficult stones and strictures. The system allows a single operator to perform procedures as well as guide devices to examine, diagnose and treat pancreaticobiliary conditions.

Learn more about the SpyGlass DS System

* U.S. Gallbladder indication is for 10mm×10mm and 15mm×10mm stents only. CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com.

** OrberaTM Intragastric Balloon System indications, safety and warnings. https://www.bostonscientific.com/content/dam/bostonscientific/endo/orbera/orbera-intragastric-balloon-system-dfu.pdf

  1. As of April 2025. Based on Boston Scientific sales data since 2005 for the SpyGlass™ legacy device system, SpyGlass™ DS and SpyGlass™ DS II.
  2. As of Q1 2025. Based on Boston Scientific sales data.
  3. Bang et al. Equivalent performance of single-use and reusable duodenoscopes in a randomized trial. Gut 2020;0:1-7.
  4. Muthusamy et al. Clinical Evaluation of a Single-Use Duodenoscope for Endoscopic Retrograde Cholangiopancreatography. Clinical Gastroenterology and Hepatology 2020:1-10.
  5. Napolean et al. Evaluation of the performance of a single-use duodenoscope: Prospective multi-center national study, Digestive Endoscopy 2021:1-7.
  6. Slivka A et al. Single-use duodenoscope for ERCP performed by endoscopists with a range of experience in procedures of variable complexity. Gastrointest Endosc. 2021 Jun 26:S0016-5107(21)01464-4. doi: 10.1016/j.gie.2021.06.017. Epub ahead of print. PMID: 34186052.
  7. Shahid et al. Comparing the Safety and Efficacy of Two Commercially Available Single-Use Duodenoscopes. 2022 Aug 24. doi: 10.1097/MCG.0000000000001752.
  8. D. Persyn et al. Performance and applicability of a first generation single-use duodenoscope: a single-center cohort study. Annals of Gastroenterology (2022) 35, 368-375.
  9. Bruno MJ, et al. Global prospective case series of ERCPs using a single-use duodenoscope. Endoscopy. 2023 Dec;55(12):1103-1114. Sponsored in part by Boston Scientific.
  10. Sesock, Charaighn.” Five-Year Survival Rate for Pancreatic Cancer Increased to 13% Signaling More Progress and More Hope for Patients.” Pancreatic Cancer Action Network, 2024. https://pancan.org/press-releases/five-year-survival-rate-for-pancreatic-cancer-increased-to-13-signaling-more-progress-and-more-hope-for-patients/​
  11. Redondo-Cerezo E, Tendero-Peinado C, López-Tobaruela JM, et al. Risk factors for massive gastrointestinal bleeding occurrence and mortality: A prospective single-center study. Am J Med Sci. 2024;367(4):259-267. doi:10.1016/j.amjms.2024.01.012​
  12. HCHS Data Brief, No. 508, September 2024. U.S. Centers for Disease Control and Prevention. https://www.cdc.gov/nchs/data/databriefs/db508.pdf. Accessed May 28, 2025​​
  13. Antimicrobial Resistance Facts and Stats.” CDC. 2024. https://www.cdc.gov/antimicrobial-resistance/data-research/facts-stats/index.html​

CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings, and instructions for use can be found in the product labelling supplied with each device or at www.IFU-BSCI.com. Products shown for INFORMATION purposes only and may not be approved or for sale in certain countries. This material not intended for use in France.